Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 701
interventional 623
Observational 75
Registry 3

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug|placebo 274
Drug 194
Biological|placebo 40
Biological 23
Other 20
Procedure 11
Device 9
Dietary Supplement|placebo 8
Device|placebo 7
Dietary Supplement 5
Drug|Other 5
Biological|Drug 4
Biological|Drug|placebo 3
Biological|Other 3
Drug|Procedure 3
Other|placebo 3
Diagnostic Test 2
Drug|Other|placebo 2
Behavioral|Device|placebo|Procedure 1
Biological|Procedure 1
Device|Drug 1
Device|Drug|placebo 1
Diagnostic Test|Other 1
Dietary Supplement|Drug|placebo 1
Other|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 171
NA 140
Canada 39
Germany 35
Austria 19
Korea, Republic of 19
United Kingdom 18
China 16
Japan 15
Spain 12
Sweden 12
Thailand 12
Italy 11
Denmark 8
Taiwan 7
United States|Canada 7
France 6
Poland 6
Switzerland 5
NA 4
Australia 4
Belgium 4
Brazil 4
Finland 3
Norway 3
Hong Kong 2
India 2
Netherlands 2
Russian Federation 2
Singapore 2
Argentina|Australia|Korea, Republic of|Russian Federation 1
Austria|Belgium|Germany|Netherlands|Spain 1
Belarus|Russian Federation 1
Belgium|Germany|Netherlands|Poland 1
Belgium|Netherlands 1
Bulgaria 1
Canada|United States|Argentina|Chile|France|Italy|Peru 1
Croatia 1
Czech Republic|Denmark|Estonia|Finland|France|Germany|Latvia|Lithuania|Poland|Slovakia|Sweden 1
Czech Republic|Germany|Poland 1
Denmark|Finland|France|Germany|Lithuania|Poland|Russian Federation|Sweden 1
Denmark|Finland|Germany|Lithuania|Norway|Poland|Slovakia|Sweden 1
Estonia|Latvia|Lithuania|Netherlands|Russian Federation|Sweden 1
Germany|Lithuania|Poland 1
Germany|Poland 1
Germany|United Kingdom 1
Hungary 1
Hungary|Poland|United Kingdom 1
Hungary|Spain 1
Mexico 1
Netherlands|United Kingdom 1
Pakistan 1
Philippines 1
Poland|Denmark|France|Latvia|Lithuania|Sweden|Switzerland 1
Spain|Sweden 1
Sweden|Ukraine 1
United States|Argentina|Chile|Finland|Italy|Mexico|Slovakia 1
United States|Australia|Canada|Estonia|Germany|Latvia|Lithuania|New Zealand|Russian Federation 1
United States|Canada|Estonia|Germany|Hungary|Russian Federation|Slovakia 1
United States|Canada|Estonia|Poland 1
United States|France 1
United States|Poland|Russian Federation|Spain 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 454
2 27
3 10
4 13
5 8
6 11
7 11
8 5
9 3
10 2
11 2
12 2
13 2
14 2
15 3
16 1
17 1
18 1
19 1
20 1
22 2
23 3
24 3
25 1
26 3
28 3
29 1
30 3
31 4
32 1
33 1
34 3
35 3
36 1
37 2
38 1
39 3
41 2
42 2
43 3
44 1
45 3
49 1
56 1
59 1
60 2
63 1
65 1
66 2
71 1
74 2
80 1
121 1

Phase

Phase Study_Count
Phase 3 202
Phase 4 129
Phase 2 122
N/A 79
Phase 1 62
Phase 1/Phase 2 15
Phase 2/Phase 3 12
Early Phase 1 2

Number of Arms

Number_of_Arms Count_of_Studies
1 63
2 279
3 111
4 57
5 21
6 9
7 2
8 2
16 1
NA 78

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 21.00 6.0000 6.00000 12.0000 18.0000 15.00 1.0000 7.0000
1st Qu. 27.25 24.0000 24.50000 32.0000 46.2500 39.50 127.0000 41.0000
Median 33.50 49.0000 34.00000 48.0000 87.0000 101.00 351.0000 100.0000
Mean 33.50 115.8846 70.27419 115.7333 197.4016 207.00 465.9204 200.4651
3rd Qu. 39.75 71.5000 53.25000 81.0000 265.7500 209.75 634.0000 299.0000
Max. 46.00 2701.0000 1307.00000 800.0000 1111.0000 784.00 2388.0000 1260.0000

Trial Group Type

group_type Group_Count
Experimental 648
Placebo Comparator 363
Active Comparator 328
NA 78
Other 25
No Intervention 13
Sham Comparator 10

Intervention Model

intervention_model Study_Count
Parallel Assignment 418
Crossover Assignment 124
Single Group Assignment 68
Factorial Assignment 7
NA 4
Sequential Assignment 2

Primary Purpose

primary_purpose Study_Count
Treatment 508
NA 36
Basic Science 25
Prevention 19
Diagnostic 16
Other 11
Supportive Care 4
Health Services Research 2
Screening 2

Observational Studies

Studies by Country

Country Study_Count
NA 18
United States 12
Germany 10
Italy 5
France 4
Canada 3
Korea, Republic of 3
Israel 2
Poland 2
Spain 2
Thailand 2
United Kingdom 2
Austria 1
Belgium 1
Denmark 1
Hong Kong 1
Indonesia|Singapore 1
Japan 1
Lithuania 1
Singapore 1
Switzerland 1
Turkey 1

Sites per Study

Site_count Study_Count
1 68
2 3
3 1
5 1
10 1
15 1

Enrollment Metrics

Measure Observational
Min 1.000
1st Qu 50.000
Median 140.500
Mean 2245.068
3rd Qu 630.000
Max 100000.000

Observation Model

observational_model Study_Count
Cohort 28
Case-Only 10
NA 10
Case-Control 9
Other 7
Case Control 5
Ecologic or Community 5
Natural History 1

Time Perspective

time_perspective Study_Count
Prospective 48
Cross-Sectional 9
Retrospective 9
NA 6
Cross-Sectional, Prospective 1
Longitudinal, Prospective 1
Other 1

Registries

Studies by Country

Country Study_Count
Austria 1
Thailand 1
United States 1

Sites per Study

Site_count Study_Count
1 2
46 1

Enrollment Metrics

Measure Registries
Min 32
1st Qu 266
Median 500
Mean 452
3rd Qu 662
Max 824

Registry Model

observational_model Study_Count
Cohort 3

Time Perspective

time_perspective Study_Count
Prospective 3

Follow-up

target_duration Study_Count
6 Months 2
2 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03363698 MCT and Capsaicin Provocation Challenge in Diagnosis of Chronic Cough https://ClinicalTrials.gov/show/NCT03363698 Recruiting Medical University of Warsaw 2021-09-30
NCT03324100 Integrative Omics Approach to Allergic Rhinitis https://ClinicalTrials.gov/show/NCT03324100 Active, not recruiting Medical University of Graz 2020-03-01
NCT03286049 Short and Mid-term Repeatability of Active Anterior Rhinomanometry (AAR) Measurements in Paediatric Age https://ClinicalTrials.gov/show/NCT03286049 Completed Istituto per la Ricerca e l’Innovazione Biomedica 2018-07-31
NCT03276416 RAPP-children, Rhinitis & Asthma in Patient Perspective: Development and Validation of a Questionnaire for Quality of Life Evaluation in Children With Asthma and Allergic Rhinitis https://ClinicalTrials.gov/show/NCT03276416 Completed Istituto per la Ricerca e l’Innovazione Biomedica 2019-07-31
NCT03251157 Dietary Intake in Adults From the GA2LEN Folow-up Survey https://ClinicalTrials.gov/show/NCT03251157 Completed Johns Hopkins Bloomberg School of Public Health 2010-12-31
NCT03112252 App Based Study on the Symptoms of Patients With Allergic Rhinitis in the Pollen Season https://ClinicalTrials.gov/show/NCT03112252 Completed University Hospital of Cologne 2017-08-31
NCT03101618 Animal Allergy in Korean Pet Owners, Pet-related Industry Workers, and Laboratory Animal Reseachers https://ClinicalTrials.gov/show/NCT03101618 Completed Gachon University Gil Medical Center 2016-11-27
NCT03097432 Non-interventional Study to Assess the Tolerability, the Safety Profile and the Adherence of Different Up-dosing Schemes for a Sublingual Immunotherapy Treatment https://ClinicalTrials.gov/show/NCT03097432 Completed University Hospital of Cologne 2017-10-19
NCT03070288 RGB(Red- Green-Blue) Measurement of the Nasal Mucosal Image https://ClinicalTrials.gov/show/NCT03070288 Completed Bezmialem Vakif University 2018-03-01
NCT03014661 Untersuchung Zur Erfassung Und Kontrolle Der Lebensqualität Unter Einer Therapie Mit Pollinex Quattro Bei Heuschnupfen https://ClinicalTrials.gov/show/NCT03014661 Completed Saarland University 2015-12-31
NCT02866864 Animal Allergy in Korean Veterinary Researcher https://ClinicalTrials.gov/show/NCT02866864 Completed Gachon University Gil Medical Center 2016-08-26
NCT02856282 Drug Utilization Study for Pirinase Hayfever Relief https://ClinicalTrials.gov/show/NCT02856282 Completed GlaxoSmithKline 2018-03-31
NCT02745418 The Role of Filaggrin Mutations and Sensitization Pathways in Allergic Rhinitis and Peanut Allergy https://ClinicalTrials.gov/show/NCT02745418 Recruiting Queen’s University 2019-08-31
NCT02636933 Longitudinal Observational Study in Prematurely Born Preschool Children: Assessment of Lung Function Parameters https://ClinicalTrials.gov/show/NCT02636933 Recruiting Istituto per la Ricerca e l’Innovazione Biomedica 2020-12-31
NCT02609581 Tolerability of SLIT With LAIS® Mites Allergoid Tablets https://ClinicalTrials.gov/show/NCT02609581 Completed University Hospital of Cologne 2017-02-28
NCT02409550 CARATKids: Italian Validation of Asthma and Allergic Rhinitis Control Test in Children https://ClinicalTrials.gov/show/NCT02409550 Completed Istituto per la Ricerca e l’Innovazione Biomedica 2016-07-31
NCT02380495 “Studio NaVA” - National Study on Quality of Life in Adolescents Affected by Allergic Rhinitis With or Without Asthma https://ClinicalTrials.gov/show/NCT02380495 Completed Istituto per la Ricerca e l’Innovazione Biomedica 2017-03-31
NCT02295969 Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis https://ClinicalTrials.gov/show/NCT02295969 Completed Stallergenes Greer 2017-07-03
NCT02238236 Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and Pruritus https://ClinicalTrials.gov/show/NCT02238236 Completed Boehringer Ingelheim 2008-04-30
NCT02238223 Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® Tablet https://ClinicalTrials.gov/show/NCT02238223 Completed Boehringer Ingelheim 2006-05-31
NCT02230475 Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes. https://ClinicalTrials.gov/show/NCT02230475 Completed Queen’s University 2014-09-30
NCT01318954 The Effect of Allergen Immunotherapy on Exhaled Nitric Oxide in Adult Patients With Asthma and Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01318954 Completed Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C. 2011-06-30
NCT02133053 Application of Ectoin Allergy Nasal Spray in Comparison to Beclomethasone Nasal Spray https://ClinicalTrials.gov/show/NCT02133053 Completed Bitop AG 2011-07-31
NCT02131051 Application of Ectoine Containing Nasal Spray and Eye Drops in Patients With Allergic Rhinitis https://ClinicalTrials.gov/show/NCT02131051 Completed Bitop AG 2010-09-30
NCT02131038 Application of Ectoine Nasal Spray in Comparison With Cromolyn Sodium Containing Nasal Spray in Patients With Allergic Rhinitis https://ClinicalTrials.gov/show/NCT02131038 Completed Bitop AG 2009-09-30
NCT01295255 Interaction Effect of Asthma and Aeroallergen Category on the Psychological Status in Allergic Rhinitis Patients https://ClinicalTrials.gov/show/NCT01295255 Completed Beijing Tongren Hospital 2009-10-31
NCT02020902 Post Marketing Surveillance for Contac Bien Z in Japan https://ClinicalTrials.gov/show/NCT02020902 Completed GlaxoSmithKline 2016-01-31
NCT01953471 Prospective Observational Study for Determination of Minimal Clinically Important Difference of Allergic Rhinitis Symptoms Due to Grass Pollen (Equinoxe 2) https://ClinicalTrials.gov/show/NCT01953471 Completed Hopital Foch 2011-09-30
NCT01936818 Study Evaluating Nasal Symptoms Induced by a Nasal Allergen Challenge (NAC) To House Dust Mite Allergen https://ClinicalTrials.gov/show/NCT01936818 Completed ORA, Inc. 2015-01-31
NCT01897506 Assessing Risk of Food Insecurity Within Households of Children With Food Allergy https://ClinicalTrials.gov/show/NCT01897506 Completed Arkansas Children’s Hospital Research Institute 2015-12-31
NCT01854580 Evaluation of an Integrated Care Project https://ClinicalTrials.gov/show/NCT01854580 Completed Charite University, Berlin, Germany 2018-12-31
NCT01845051 Is There a Comorbidity Between Migraine and Allergic Rhinitis? https://ClinicalTrials.gov/show/NCT01845051 Completed Baskent University 2013-03-31
NCT01777438 Evaluating Symptom Control in in Allergic Rhinitis at Three Years After Starting Immunotherapy https://ClinicalTrials.gov/show/NCT01777438 Completed Universitaire Ziekenhuizen Leuven 2013-06-30
NCT01699659 The Efficacy & Safety of the UAS Immunotherapy Protocol https://ClinicalTrials.gov/show/NCT01699659 Completed United Allergy Services 2012-09-30
NCT01686048 The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel https://ClinicalTrials.gov/show/NCT01686048 Completed Meir Medical Center 2015-04-30
NCT01686022 Grass Sensitisation and Allergic Rhinitis in Thai Patients https://ClinicalTrials.gov/show/NCT01686022 Completed Mahidol University 2015-10-31
NCT01553110 An Observational Study to Evaluate The Relationship of Nasal Mucus Properties and Symptoms https://ClinicalTrials.gov/show/NCT01553110 Completed Virginia Commonwealth University 2018-12-31
NCT01549340 Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022) https://ClinicalTrials.gov/show/NCT01549340 Completed ALK-Abelló A/S 2012-05-31
NCT01489293 Inhibitory Receptors in Eosinophils of Atopic Subjects https://ClinicalTrials.gov/show/NCT01489293 Completed Meir Medical Center 2013-12-31
NCT01461200 Effects of Allergic Rhinitis on the Nasal/Sinus Microbiome https://ClinicalTrials.gov/show/NCT01461200 Completed University of Chicago 2012-01-31
NCT01445262 Drug Use Investigation for XYZAL® https://ClinicalTrials.gov/show/NCT01445262 Completed GlaxoSmithKline 2013-12-31
NCT04389034 Influence of Specific Immunotherapy With Pollinex Quattro (Tree-/Grass Pollen) on Allergen-specific Immunoglobulin E (IgE) Levels https://ClinicalTrials.gov/show/NCT04389034 Recruiting Allergy Therapeutics 2020-10-31
NCT04125888 Impact of AIT on Allergic Rhinitis and Asthma https://ClinicalTrials.gov/show/NCT04125888 Active, not recruiting ALK-Abelló A/S 2020-12-31
NCT04104828 Comparison of Innate Immune Responses Induced by Allergy Immunotherapy (AIT) With Different Adjuvants https://ClinicalTrials.gov/show/NCT04104828 Recruiting University of Zurich 2020-03-31
NCT03746860 N.I.S of AIT in Adult Patients With House Dust Mite Allergy in Real Practice in France https://ClinicalTrials.gov/show/NCT03746860 Recruiting ALK-Abelló A/S 2020-05-31
NCT03714945 Study on Association Between Treatment of Allergic Rhinitis and Cognitive Ability in Children https://ClinicalTrials.gov/show/NCT03714945 Recruiting Chinese University of Hong Kong 2020-12-31
NCT03599908 Evaluation and Validation of Novel Diagnostic Tool for Allergists (AbioSCOPE) https://ClinicalTrials.gov/show/NCT03599908 Completed Centre Hospitalier Universitaire Vaudois 2016-11-14
NCT01199757 A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures https://ClinicalTrials.gov/show/NCT01199757 Completed GlaxoSmithKline 2009-08-01
NCT01192386 Eosinophil Markers and Development of Disease in Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01192386 Completed University of Aarhus 2010-05-31
NCT01129765 Home Usability of a Nasal Lavage System in Children https://ClinicalTrials.gov/show/NCT01129765 Completed Aardvark Medical Company 2009-08-31
NCT01113697 Genetics of the Early and Late Response to Allergen Challenge https://ClinicalTrials.gov/show/NCT01113697 Recruiting University of British Columbia 2020-12-31
NCT01104012 Validation of Proteomic Analyses for Allergic Asthma and Rhinitis https://ClinicalTrials.gov/show/NCT01104012 Completed Centre Hospitalier Universitaire de Nīmes 2012-10-31
NCT01077609 Flixonase Safety in Patients With Allergic Rhinitis (AR) https://ClinicalTrials.gov/show/NCT01077609 Completed GlaxoSmithKline 2010-04-30
NCT01068808 The Development of Allergic Rhinitis in Children Previously Diagnosed as Nonallergic Rhinitis https://ClinicalTrials.gov/show/NCT01068808 Completed Mahidol University 2012-06-30
NCT01001130 Regulatory AVAMYS Nasal Spray PMS https://ClinicalTrials.gov/show/NCT01001130 Completed GlaxoSmithKline 2014-05-31
NCT00903721 Nasonex® Nasal Suspension 50 μg Long-term Designated Drug Use Investigation (Study P05876) https://ClinicalTrials.gov/show/NCT00903721 Completed Merck Sharp & Dohme Corp. 2012-10-31
NCT00826189 Influence of Probiotics on Atopy With Focus on Respiratory Allergic Diseases- Follow-up to 7 Years https://ClinicalTrials.gov/show/NCT00826189 Completed National University Hospital, Singapore 2013-06-30
NCT00815984 Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic Diseases https://ClinicalTrials.gov/show/NCT00815984 Completed Medical Universtity of Lodz 2010-01-31
NCT01485523 Sensitivity and Specificity of Nasal Provocation Test in Allergic Rhinitis to House Dust Mites https://ClinicalTrials.gov/show/NCT01485523 Completed University Hospital, Strasbourg, France 2012-08-31
NCT03821077 Study to Evaluate the Efficacy and Safety of “Allergovac Poliplus” in Polysensitized Patients With Allergic Rhinitis/Rhinoconjunctivitis, With or Without Asthma https://ClinicalTrials.gov/show/NCT03821077 Active, not recruiting Roxall Medicina España S.A 2021-06-30
NCT02844842 Evaluation of Tolerability and Safety of “Allergovac Poliplus” in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice https://ClinicalTrials.gov/show/NCT02844842 Completed Roxall Medicina España S.A 2018-09-06
NCT02579720 Revaccination With Pollinex® Quattro https://ClinicalTrials.gov/show/NCT02579720 Completed University Hospital of Cologne 2015-10-31
NCT02553590 Tolerability of SLIT With LAIS® 2-Tree Allergoid Tablets https://ClinicalTrials.gov/show/NCT02553590 Completed University Hospital of Cologne 2015-10-31
NCT04352088 Immune Response Features in Allergic Airway Diseases https://ClinicalTrials.gov/show/NCT04352088 Recruiting Lithuanian University of Health Sciences 2022-11-30
NCT00762983 Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED) https://ClinicalTrials.gov/show/NCT00762983 Completed Merck Sharp & Dohme Corp. 2009-02-28
NCT00761527 Observation of Side Effects and Effectiveness of Desloratadine (Aerius) Syrup in Filipino Children (Study P05634) https://ClinicalTrials.gov/show/NCT00761527 Completed Merck Sharp & Dohme Corp. 2010-05-31
NCT00723736 Safety of Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis or Chronic Idiopathic Urticaria (Study P04446AM1)(COMPLETED) https://ClinicalTrials.gov/show/NCT00723736 Completed Merck Sharp & Dohme Corp. 2008-06-30
NCT00713089 Study of Stool Microbiota in Two Diverse Cohorts of Asian and Its Influence on Allergy Development https://ClinicalTrials.gov/show/NCT00713089 Completed National University Hospital, Singapore 2009-11-30
NCT00704769 Response of Desloratadine Syrup in the Relief of Symptoms Associated With Perennial Allergic Rhinitis in Pediatric Patients (Study P04299) https://ClinicalTrials.gov/show/NCT00704769 Completed Merck Sharp & Dohme Corp. 2007-12-31
NCT00598780 Evaluation of Safety of Levocetirizine in Routine Clinical Practice-non- Interventional Study https://ClinicalTrials.gov/show/NCT00598780 Completed UCB Pharma 2008-09-30
NCT00517946 A Study To Investigate If MRI Scanning Is Effective At Seeing What Hayfever Drugs Do In Nasal Passage. https://ClinicalTrials.gov/show/NCT00517946 Completed GlaxoSmithKline 2007-04-30
NCT00405899 Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections https://ClinicalTrials.gov/show/NCT00405899 Completed West Penn Allegheny Health System NA
NCT00297843 A Pilot Monocenter Study to Assess Cellular and Soluble Biomarkers in Nasal Secretions https://ClinicalTrials.gov/show/NCT00297843 Completed Fraunhofer-Institute of Toxicology and Experimental Medicine NA
NCT00189449 Effects of Long-Term Treatment With Nasally Inhaled Triamcinolone Acetonide in Children With Allergic Rhinitis https://ClinicalTrials.gov/show/NCT00189449 Completed West Penn Allegheny Health System NA
NCT00011440 Pollutant Altered Allergic Responses https://ClinicalTrials.gov/show/NCT00011440 Completed National Institute of Environmental Health Sciences (NIEHS) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03127436 Non-interventional Study to Assess the Tolerability and the Safety Profile of SCIT Therapy With Acarovac® Hausstaubmilbe https://ClinicalTrials.gov/show/NCT03127436 Completed University Hospital of Cologne 2019-02-14
NCT02000648 Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in Thailand https://ClinicalTrials.gov/show/NCT02000648 Completed Chulalongkorn University 2015-02-28
NCT01632540 Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis https://ClinicalTrials.gov/show/NCT01632540 Completed Teva Pharmaceutical Industries 2013-12-31